Terns Pharmaceuticals Files 8-K
Ticker: TERN · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1831363
Sentiment: neutral
Topics: 8-K, regulatory-filing, corporate-events
TL;DR
Terns Pharma dropped an 8-K on Nov 3rd - check it for Reg FD, other events, and financials.
AI Summary
Terns Pharmaceuticals, Inc. filed an 8-K on November 3, 2025, reporting on various events. The filing includes information related to Regulation FD disclosures, other events, and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Foster City, California.
Why It Matters
This 8-K filing provides an update on Terns Pharmaceuticals' corporate activities and regulatory disclosures, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting standard corporate events and disclosures, not indicating any immediate significant financial or operational changes.
Key Players & Entities
- Terns Pharmaceuticals, Inc. (company) — Registrant
- November 03, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39926 (identifier) — Commission File Number
- 1065 East Hillsdale Blvd. Suite 100 (address) — Address of Principal Executive Offices
- Foster City, California (location) — City and State of Principal Executive Offices
- 94404 (zip_code) — Zip Code of Principal Executive Offices
- (650) 525-5535 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing for Terns Pharmaceuticals, Inc.?
The primary purpose is to report on events that require current disclosure, including Regulation FD disclosures, other events, and financial statements and exhibits, as of November 3, 2025.
When was Terns Pharmaceuticals, Inc. incorporated, and where are its principal executive offices located?
Terns Pharmaceuticals, Inc. was incorporated in Delaware, and its principal executive offices are located at 1065 East Hillsdale Blvd., Suite 100, Foster City, California, 94404.
What is the Commission File Number for Terns Pharmaceuticals, Inc.?
The Commission File Number for Terns Pharmaceuticals, Inc. is 001-39926.
What is the telephone number for Terns Pharmaceuticals, Inc.?
The telephone number for Terns Pharmaceuticals, Inc., including area code, is (650) 525-5535.
What specific items are being reported under the Form 8-K filing by Terns Pharmaceuticals, Inc.?
The filing specifically lists 'Regulation FD Disclosure', 'Other Events', and 'Financial Statements and Exhibits' as items being reported.
Filing Stats: 1,638 words · 7 min read · ~5 pages · Grade level 17.6 · Accepted 2025-11-03 09:13:48
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share TERN Nasdaq Glo
Filing Documents
- d78407d8k.htm (8-K) — 47KB
- d78407dex991.htm (EX-99.1) — 27KB
- 0001193125-25-261798.txt ( ) — 201KB
- tern-20251103.xsd (EX-101.SCH) — 3KB
- tern-20251103_lab.xml (EX-101.LAB) — 18KB
- tern-20251103_pre.xml (EX-101.PRE) — 11KB
- d78407d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, issued by Terns Pharmaceuticals, Inc. on November 3, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TERNS PHARMACEUTICALS, INC. Date: November 3, 2025 By: /s/ Caryn McDowell Caryn McDowell Chief Legal Officer and Corporate Secretary